These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10756700)

  • 21. Lower urinary tract symptoms suggestive of benign prostatic obstruction--Triumph: health-economical analysis.
    McDonnell J; Busschbach JJ; Kok E; van Exel J; Stolk E; Koopmanschap M; Rutten FF
    Eur Urol; 2001; 39 Suppl 3():37-41. PubMed ID: 11275741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benign prostatic hyperplasia.
    Barry M; Roehrborn C
    Clin Evid; 2002 Jun; (7):775-87. PubMed ID: 12230703
    [No Abstract]   [Full Text] [Related]  

  • 23. Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study.
    McVary KT; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; Roehrborn CG
    J Sex Med; 2016 Jun; 13(6):924-33. PubMed ID: 27129767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of randomized controlled trials: issues to consider when designing a trial.
    Pandis N
    Am J Orthod Dentofacial Orthop; 2013 Jun; 143(6):905-7. PubMed ID: 23726342
    [No Abstract]   [Full Text] [Related]  

  • 25. Combination therapies for improved management of lower urinary tract symptoms/benign prostatic hyperplasia.
    De Nunzio C; Presicce F; Tubaro A
    Drugs Today (Barc); 2016 Sep; 52(9):501-517. PubMed ID: 27883117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interventional therapies for lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).
    Seitz M; Bader M; Tilki D; Stief C; Gratzke C
    Minerva Urol Nefrol; 2012 Jun; 64(2):123-33. PubMed ID: 22617306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extending the CONSORT statement to cluster randomized trials: for discussion.
    Elbourne DR; Campbell MK
    Stat Med; 2001 Feb; 20(3):489-96. PubMed ID: 11180315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostatic artery embolization for benign prostatic hyperplasia: a review.
    Young S; Golzarian J
    Curr Opin Urol; 2018 May; 28(3):284-287. PubMed ID: 29538167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of PDE5 inhibitors alone or in combination with alpha-blockers for the treatment of erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and meta-analysis.
    Yan H; Zong H; Cui Y; Li N; Zhang Y
    J Sex Med; 2014 Jun; 11(6):1539-45. PubMed ID: 24621088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment satisfaction of patients with lower urinary tract symptoms: randomised controlled trials vs. real life practice.
    Michel MC; Goepel M
    Eur Urol; 2000; 38 Suppl 1():40-7. PubMed ID: 11111207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate Artery Embolization for Benign Prostatic Hyperplasia: Current Status.
    Mirakhur A; McWilliams JP
    Can Assoc Radiol J; 2017 Feb; 68(1):84-89. PubMed ID: 27887933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining the role of overactive bladder treatments in men with lower urinary tract symptoms.
    Lemack GE
    Nat Clin Pract Urol; 2007 Apr; 4(4):174-5. PubMed ID: 17415351
    [No Abstract]   [Full Text] [Related]  

  • 33. Microwave thermotherapy for the treatment of benign prostatic hyperplasia.
    Blute ML
    Semin Urol; 1994 Aug; 12(3):181-92. PubMed ID: 7527925
    [No Abstract]   [Full Text] [Related]  

  • 34. The first randomized controlled trial.
    Abrams P; McNicholas TA; Donovan JL; Peters TJ; Grant A
    BJU Int; 2000 Mar; 85 Suppl 1():1-2. PubMed ID: 10756699
    [No Abstract]   [Full Text] [Related]  

  • 35. Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study.
    Roehrborn CG; Oyarzabal Perez I; Roos EP; Calomfirescu N; Brotherton B; Palacios JM; Vasylyev A; Manyak MJ
    World J Urol; 2017 Mar; 35(3):421-427. PubMed ID: 27334136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Relevant Midterm (12 Months) Placebo Effect on Lower Urinary Tract Symptoms and Maximum Flow Rate in Male Lower Urinary Tract Symptom and Benign Prostatic Hyperplasia-A Meta-analysis.
    Eredics K; Madersbacher S; Schauer I
    Urology; 2017 Aug; 106():160-166. PubMed ID: 28506862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study.
    Donovan JL; Peters TJ; Neal DE; Brookes ST; Gujral S; Chacko KN; Wright M; Kennedy LG; Abrams P
    J Urol; 2000 Jul; 164(1):65-70. PubMed ID: 10840426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benign prostatic hyperplasia.
    Clarke HS
    Am J Med Sci; 1997 Oct; 314(4):239-44. PubMed ID: 9332262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced issues in the design and conduct of randomized clinical trials: the bigger the better?
    Warlow C
    Stat Med; 2002 Oct; 21(19):2797-805. PubMed ID: 12325095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review of Cernilton for the treatment of benign prostatic hyperplasia.
    MacDonald R; Ishani A; Rutks I; Wilt TJ
    BJU Int; 2000 May; 85(7):836-41. PubMed ID: 10792162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.